about
Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials.Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patients.Incretin-based therapy and acute cholecystitis: a review of case reports and EudraVigilance spontaneous adverse drug reaction reporting database.Liraglutide and obesity in elderly: efficacy in fat loss and safety in order to prevent sarcopenia. A perspective case series study.
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Liraglutide-related cholelithiasis.
@en
Liraglutide-related cholelithiasis.
@nl
type
label
Liraglutide-related cholelithiasis.
@en
Liraglutide-related cholelithiasis.
@nl
prefLabel
Liraglutide-related cholelithiasis.
@en
Liraglutide-related cholelithiasis.
@nl
P2093
P2860
P1476
Liraglutide-related cholelithiasis
@en
P2093
Ersin Akarsu
Hakan Korkmaz
Mustafa Araz
P2860
P2888
P304
P356
10.1007/S40520-015-0335-2
P50
P577
2015-03-01T00:00:00Z